Skip to content
GC
Company

Updated:

GENZYME CORP

GENZYME CORP is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0000732485, and its reported industry is...

Overview

GENZYME CORP is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0000732485, and its reported industry is Biological Products, (No Diagnostic Substances). In 10-K filed on 2011-03-01, it reported annual revenue of USD 4,048,708,000; total assets of USD 10,913,854,000 for the fiscal period ended 2010-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

Company overview

Legal name
GENZYME CORP
Classification
Company
Industry (SIC)
2836 — Biological Products, (No Diagnostic Substances)
Headquarters
Cambridge, MA, United States
Incorporated in
MA
Fiscal year end
December 31
SEC CIK
0000732485

Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

Fiscal yearPeriod endRevenueTotal assetsCash and equivalentsOperating cash flow
FY2010USD$4.0B$10.9B$1.3B$487.0M
FY2009USD$4.5B$10.1B$742.2M$1.2B

FY2009. Revenue: shown as originally filed; later filings report different values for the same periods.

Recent SEC filings

FormFiledPeriodFiling
SC 13D—SCHEDULE 13D
8-KFORM 8-K
8-KFORM 8-K
10-K/AFORM 10-K/A
10-KFORM 10-K
8-KFORM 8-K
SC 13G—Form SC 13G
SC 13G—Form SC 13G
8-KFORM 8-K
8-KFORM 8-K
10-QFORM 10-Q
8-KGENZYME, INC.

Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.

Research GENZYME CORP in Altss

Track this company’s investors, transactions and relationships in Altss.

Book a demo

More Company profiles

GENZYME CORP | Cambridge Company | Altss